Mayo Clinic Maintenance of Certification in Anesthesia (MOCA) Simulation 2025 Course

  07 Mar 2025 - 07 Mar 2025

   Phoenix, AZ, United States

conference-img

Mayo Clinic Maintenance of Certification in Anesthesia (MOCA) Simulation 2025 Course

07 Mar 2025

 - 

07 Mar 2025

Phoenix, AZ, United States



This is a 1-day, simulation-based course that fulfills the simulation requirements for Part IV of MOCA. It consists of a series of simulation scenarios followed by debriefing periods with a variety of anesthetic challenges.

Participants will be sharing the day with other anesthesiologists. Cases are ones that any board-certified anesthesiologist ought to be striving to manage and consist of team management skills, as well as skills managing hemodynamic and respiratory instability. Participants are informed there is no graded test.

International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026


International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

2.

EVP Beats Cisplatin for Resectable MIBC

3.

For elderly, unfit patients, the all-oral AML regimen shows promise.

4.

Study sets benchmark for treatment of advanced cervical cancer

5.

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot